Stem Cell Immunogenicity

Foreseeing the immunogenicity of a stem cell therapy is fundamental to empower sheltered and powerful procedures for anticipating invulnerable assault to be outlined. The immunogenicity of autologous prompted PSCs (iPSCs) changes between clones. Undifferentiated immature microorganisms are more immunogenic than their separated offspring. Distinctive kinds of tissue separated from a similar foundational microorganism can show diverse levels of immunogenicity. Stem cells jumbled with the patient for real histocompatibility complex (MHC) as well as minor histocompatibility (miH) antigens are immunogenic. miH antigen contrasts can be acquainted by the advancements utilized with creating pluripotent immature microorganisms (PSC, for example, confused mitochondrial antigens present in the enucleated oocytes used to deliver atomic exchange embryonic foundational microorganisms (NT-ESC).

 

  • Embryonic Stem Cells
  • Cell Therapy
  • Allogeneic Immune Rejection
  • Immune Tolerance
  • Pluripotent Stem Cells
  • Stem Cell Transplantation
  • ELISPOT
  • Major Histocompatibility Complex

Stem Cell Immunogenicity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in